Insuficiencia cardiaca

Los estudios sobre insuficiencia cardiaca siempre concitan una gran expectación en los congresos internacionales. El ESC Congress 2008 no fue una excepción y presentó un atractivo programa de sesiones sobre el tema que ahora puedes consultar en los siguientes webcast.

Insuficiencia cardiaca

Mesa científica	Título	Ponente
Heart Failure (HF) with normal ejection fraction	Diagnostic strategy	Paulus W J (Amsterdam, NL)
Heart Failure (HF) with normal ejection fraction	Any specific treatment?	McMurray J J V (Glasgow, GB)
Hot Line I	Trial of Intensified (BNP-guided) versus standard (symptom-guided) Medical therapy in Elderly patients with Congestive Heart Failure (HF) TIME-CHF - Discussant	Dickstein K (Stavanger, NO)
Hot Line I	Effects of n-3 PUFA in patients with symptomatic chronic Heart Failure (HF): the GISSI-HF results	Tavazzi L (Pavia, IT)
Hot Line I	Effects of n-3 PUFA in patients with symptomatic chronic Heart Failure (HF): the GISSI-HF results - Discussant	Komajda M (Paris, FR)
Hot Line I	Effects of statins in patients with symptomatic chronic Heart Failure (HF): the GISSI-HF results	Tognoni G (Milan, IT)
Hot Line I	Effects of statins in patients with symptomatic chronic Heart Failure (HF): the GISSI-HF results - Discussant	Poole-Wilson P A (London, GB)
Hot Line I	The TRANSCEND Study: a randomized placebo-controlled clinical trial evaluating the effects of telmisartan in high risk individuals without Heart Failure (HF) - Discussant	Swedberg K (Goteborg, SE)
Fallacies from clinical trials	Heart Failure (HF)	Swedberg K (Goteborg, SE)
Moving from cure to palliation	Palliative care in Heart Failure (HF) patients	Jaarsma T (Groningen, NL)
Evolving role of echo in Heart Failure (HF)	Evaluating patients with Heart Failure (HF) symptoms	Pinto F J (Lisbon, PT)
Evolving role of echo in Heart Failure (HF)	Viability assessment - how to use the data	Pierard L A (Liege, BE)
Evolving role of echo in Heart Failure (HF)	Role of contrast - assessing the microvasculature	Senior R (Harrow, GB)
Evolving role of echo in Heart Failure (HF)	New approaches to left ventricular function	Vannan M (Columbus, US)
Cardiac magnetic resonance imaging in Heart Failure (HF)	Case 1: value of echocardiography	Pinto F J (Lisbon, PT)
Cardiac magnetic resonance imaging in Heart Failure (HF)	Discussion case 1	Pinto F J (Lisbon, PT), A C Van Rossum (Amsterdam, NL)
Cardiac magnetic resonance imaging in Heart Failure (HF)	Case 2: value of cardiovascular magnetic resonance imaging	Van Rossum A C (Amsterdam, NL)
The new ESC guidelines	Heart Failure (HF)	Dickstein K (Stavanger, NO)
2008 ESC Heart Failure (HF) guidelines: what's new?	Diagnosis	Poole-Wilson P A (London, GB)
2008 ESC Heart Failure (HF) guidelines: what's new?	Drug therapy	Boehm M (Homburg/Saar, DE)
2008 ESC Heart Failure (HF) guidelines: what's new?	Devices	Priori S G (Pavia, IT)
2008 ESC Heart Failure (HF) guidelines: what's new?	Implementation	Dickstein K (Stavanger, NO)
Clinical Trial Update II	Results from the BACH (Biomarkers in ACute Heart Failure (HF)) Trial	Maisel A (San Diego, US)
Clinical Trial Update II	Results from the BACH (Biomarkers in ACute Heart Failure (HF)) Trial - Discussant	McDonagh T A (London, GB)
Clinical Trial Update II	Changes in clinical, neurohormonal, electrolyte, renal, hematological and hepatic profiles during and after hospitalization for acute decompensated Heart Failure (HF): Analysis from the EVEREST trial	Gheorghiade M (Chicago, US)
Clinical Trial Update II	Changes in clinical, neurohormonal, electrolyte, renal, hematological and hepatic profiles during and after hospitalization for acute decompensated Heart Failure (HF): Analysis from the EVEREST trial - Discussant	Tendera M (Katowice, PL)
Clinical Trial Update III	Progressive reverse remodeling in patients with mild or asymptomatic Heart Failure (HF) with previous symptoms in the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study	Linde C (Stockholm, SE)
Clinical Trial Update III	Progressive reverse remodeling in patients with mild or asymptomatic Heart Failure (HF) with previous symptoms in the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. - Discussant	Vardas P E (Heraklion, GR)
State of the Art - Novel therapies in Heart Failure (HF)	Prediction of survival in patients with cardiogenic shock and multiorgan failure treated with biventricular assist devices and the total artificial heart	Potapov E V (Berlin, DE)
State of the Art - Novel therapies in Heart Failure (HF)	Twelve month follow-up of improvement of human infarcted heart muscle by intracoronary autologous mononuclear bone marrow cells in chronic coronary artery disease after myocardial infarction (IACT)	Koestering M (Duesseldorf, DE)
State of the Art - Novel therapies in Heart Failure (HF)	Effects of testosterone supplementation in elderly female patients with chronic Heart Failure (HF)	Caminiti G (Rome, IT)
State of the Art - Novel therapies in Heart Failure (HF)	Independent and additive influence of carvedilol and ivabradine on long-term prognosis in patients with severe chronic Heart Failure (HF) of ischemic origin	Tumasyan L R (Yerevan, AM)
State of the Art - Novel therapies in Heart Failure (HF)	State of the Art - Building on the success of Heart Failure (HF) therapies	Pfeffer M (Boston, US)
Hot Line I	Trial of Intensified (BNP-guided) versus standard (symptom-guided) Medical therapy in Elderly patients with Congestive Heart Failure TIME-CHF	H P Brunner-La Rocca (Basel, CH)

Cardiología hoy | Blog

Guías clínicas

Agenda SEC

CardioPODCAST

Cursos SEC

Másteres y Posgrados

Formación SEC 2025

CardioTV

Insuficiencia cardiaca

Insuficiencia cardiaca

Actualidad

Revista Española de Cardiología

REC: Interventional Cardiology

REC: CardioClinics

Socios estratégicos